143 related articles for article (PubMed ID: 9074796)
21. In K562 leukemia cells treated with doxorubicin and hemin, a decrease in c-myc mRNA expression correlates with loss of self-renewal capability but not with erythroid differentiation.
Toffoli G; Viel A; Bevilacqua C; Maestro R; Tumiotto L; Boiocchi M
Leuk Res; 1989; 13(4):279-87. PubMed ID: 2654492
[TBL] [Abstract][Full Text] [Related]
22. Effects of inducers of erythroid differentiation of human leukemia K562 cells on vincristine-resistant K562/VCR cells.
Okabe-Kado J; Hayashi M; Honma Y; Hozumi M; Tsuruo T
Leuk Res; 1983; 7(4):481-5. PubMed ID: 6684716
[TBL] [Abstract][Full Text] [Related]
23. Involvement of peripheral-type benzodiazepine receptors in the intracellular transport of heme and porphyrins.
Taketani S; Kohno H; Furukawa T; Tokunaga R
J Biochem; 1995 Apr; 117(4):875-80. PubMed ID: 7592553
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract][Full Text] [Related]
25. [Modulation of the expression of transferrin receptors by iron, hemin and protoporphyrin IX].
Louache F; Testa U; Thomopoulos P; Titeux M; Rochant H
C R Seances Acad Sci III; 1983; 297(6):291-4. PubMed ID: 6318930
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
27. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
[TBL] [Abstract][Full Text] [Related]
28. ERK signaling pathway is differentially involved in erythroid differentiation of K562 cells depending on time and the inducing agent.
Woessmann W; Zwanzger D; Borkhardt A
Cell Biol Int; 2004; 28(5):403-10. PubMed ID: 15193284
[TBL] [Abstract][Full Text] [Related]
29. Max and inhibitory c-Myc mutants induce erythroid differentiation and resistance to apoptosis in human myeloid leukemia cells.
Cañelles M; Delgado MD; Hyland KM; Lerga A; Richard C; Dang CV; León J
Oncogene; 1997 Mar; 14(11):1315-27. PubMed ID: 9178892
[TBL] [Abstract][Full Text] [Related]
30. Spi-1/PU.1 proto-oncogene induces opposite effects on monocytic and erythroid differentiation of K562 cells.
Delgado MD; Gutiérrez P; Richard C; Cuadrado MA; Moreau-Gachelin F; León J
Biochem Biophys Res Commun; 1998 Nov; 252(2):383-91. PubMed ID: 9826539
[TBL] [Abstract][Full Text] [Related]
31. Human leukemic K562 cells treated with cytosine arabinoside: enhancement of erythroid differentiation by retinoic acid and retinol.
Cortesi R; Gui V; Osti F; Nastruzzi C; Gambari R
Eur J Haematol; 1998 Nov; 61(5):295-301. PubMed ID: 9855243
[TBL] [Abstract][Full Text] [Related]
32. c-myb but not c-myc suppresses the hemin-induced nonterminal expression of hemoglobin by murine erythroleukemia cells.
Prochownik EV
Blood; 1989 Feb; 73(3):782-6. PubMed ID: 2644989
[TBL] [Abstract][Full Text] [Related]
33. Effects of overexpression of the Ets family transcription factor TEL on cell growth and differentiation of K562 cells.
Sakurai T; Yamada T; Kihara-Negishi F; Teramoto S; Sato Y; Izawa T; Oikawa T
Int J Oncol; 2003 Jun; 22(6):1327-33. PubMed ID: 12739001
[TBL] [Abstract][Full Text] [Related]
34. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.
Schroeder C; Gibson L; Zenke M; Beug H
Oncogene; 1992 Feb; 7(2):217-27. PubMed ID: 1347914
[TBL] [Abstract][Full Text] [Related]
35. Growth-inhibition by hemin in K562 human leukemic cells is related to hemoglobin-producing activity.
Sasaki D; Kosunago S; Mikami T; Matsumoto T; Suzuki M
Biol Pharm Bull; 1994 May; 17(5):586-90. PubMed ID: 7920413
[TBL] [Abstract][Full Text] [Related]
36. Erythroid properties of K562 cells. Effect of hemin, butyrate and TPA induction.
Villeval JL; Pelicci PG; Tabilio A; Titeux M; Henri A; Houesche F; Thomopoulos P; Vainchenker W; Garbaz M; Rochant H; Breton-Gorius J; Edwards PA; Testa U
Exp Cell Res; 1983 Jul; 146(2):428-35. PubMed ID: 6575918
[TBL] [Abstract][Full Text] [Related]
37. Hemin inhibits the interferon-beta-induced antiviral state in established cell lines.
Fiorucci G; Percario ZA; Coccia EM; Battistini A; Rossi GB; Romeo G; Affabris E
J Interferon Cytokine Res; 1995 May; 15(5):395-402. PubMed ID: 7544231
[TBL] [Abstract][Full Text] [Related]
38. Role of G proteins and ERK activation in hemin-induced erythroid differentiation of K562 cells.
Kucukkaya B; Arslan DO; Kan B
Life Sci; 2006 Feb; 78(11):1217-24. PubMed ID: 16216279
[TBL] [Abstract][Full Text] [Related]
39. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells.
Delgado MD; Lerga A; Cañelles M; Gómez-Casares MT; León J
Oncogene; 1995 Apr; 10(8):1659-65. PubMed ID: 7731722
[TBL] [Abstract][Full Text] [Related]
40. Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562.
Tonini GP; Radzioch D; Gronberg A; Clayton M; Blasi E; Benetton G; Varesio L
Cancer Res; 1987 Sep; 47(17):4544-7. PubMed ID: 3476195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
